2 ASX blue chip shares that are kicking goals in FY 2021

Goodman Group (ASX:GMG) and this ASX share are two blue chips in form in FY 2021. Here’s what you need to know…
The post 2 ASX blue chip shares that are kicking goals in FY 2021 appeared first on Motley Fool Australia. –

One group of shares that are popular with investors are blue chips.

Blue chip shares tend to be companies that are well-known, long-established, and have strong financial positions. In other words, they are not going anywhere any time soon, which makes them safer than the average share.

Though, it is worth remembering that not all blue chip ASX shares are equal and some are better than others.

Two blue chips that are on form in FY 2021 are listed below. Here’s what you need to know about them:

Goodman Group (ASX: GMG)

Goodman Group is an integrated commercial and industrial property group. It has been growing at a strong rate in recent years thanks to management’s focus on high-quality properties in key locations that it believes will deliver sustainable returns for investors. These include logistics and warehouse facilities which have exposure to the growing ecommerce market through relationships with Amazon, DHL, and Walmart.

At the end of the first quarter of FY 2021, the company reported 2.9% like-for-like net property income growth across its managed partnerships. It also revealed 97.8% occupancy across its partnerships and $7.3 billion of development work in progress. The latter was ahead of its guidance.

This update went down well with analysts at Morgan Stanley. They have retained their overweight rating and $20.90 price target on the company’s shares. It notes that Goodman is expecting more developments over the remainder of FY 2021, with higher yields.

Sonic Healthcare Limited (ASX: SHL)

Sonic Healthcare is a blue chip share in form. It recently released its first quarter update and revealed very strong revenue and earnings growth. For the three months ended 30 September, the company delivered a 29% increase in revenue to $2,144 million and a massive 71% lift in EBITDA to $580 million. The majority of this strong growth was driven by increasing demand for COVID-19 testing services globally. Though, it is worth noting that the rest of the business performed positively as well.

This was another update that went down well with Morgan Stanley. In response to the update, it retained its overweight rating and lifted its price target to $40.00. The broker believes that its earnings from COVID-19 testing could remain stronger for longer. It suspects this could lead to a sustained re-rating of its shares.

Looking For Bargain Buys? These Cheap Stocks Could Be Just What You’re After (FREE REPORT)

Scott Phillips has released a FREE stock report revealing 5 stocks that he believes are WAY undervalued by the market at these current prices.

Scott thinks these 5 stocks are a ‘must consider’ for any savvy investor.

Don’t miss out! Simply click the link below to grab your free copy and discover Scott’s 5 bargain stocks now.

Click Here For Your Free Stock Report

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 2 ASX blue chip shares that are kicking goals in FY 2021 appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!